Current
$29.67B
5-Year Average
$41.10B
All-Time High
$70.06B
All-Time Low
$41.18M
Market cap daily chart for DexCom (DXCM)
Jun 16, 2021 – Jun 12, 2026 · 1,254 trading days
Market Cap growth chart for DexCom (DXCM) from 2005 to 2026
Latest: +10.2%
Market Cap history table for DexCom (DXCM) from 2005 to 2026
| 2026 | $29.67B | +10.2% | +$2.75B | ||
| 2025 | $26.91B | -16.1% | −$5.18B | ||
| 2024 | $32.10B | -39.2% | −$20.70B | ||
| 2023 | $52.80B | +9.1% | +$4.39B | ||
| 2022 | $48.41B | -15.9% | −$9.15B | ||
| 2021 | $57.56B | +59.7% | +$21.51B | ||
| 2020 | $36.05B | +78.5% | +$15.86B | ||
| 2019 | $20.19B | +91.1% | +$9.63B | ||
| 2018 | $10.57B | +113.3% | +$5.61B | ||
| 2017 | $4.95B | -0.8% | −$38.97M | ||
| 2016 | $4.99B | -23.6% | −$1.54B | ||
| 2015 | $6.54B | +57.9% | +$2.40B | ||
| 2014 | $4.14B | +64.4% | +$1.62B | ||
| 2013 | $2.52B | +169.4% | +$1.58B | ||
| 2012 | $934.32M | +52.8% | +$322.93M | ||
| 2011 | $611.39M | -21.2% | −$164.72M | ||
| 2010 | $776.12M | +116.6% | +$417.79M | ||
| 2009 | $358.32M | +340.3% | +$276.94M | ||
| 2008 | $81.38M | -67.5% | −$168.90M | ||
| 2007 | $250.29M | -7.0% | −$18.80M | ||
| 2006 | $269.09M | -4.8% | −$13.56M | ||
| 2005 | $282.65M | — | — |
- 2026$29.67B+10.2%
- 2025$26.91B-16.1%
- 2024$32.10B-39.2%
- 2023$52.80B+9.1%
- 2022$48.41B-15.9%
- 2021$57.56B+59.7%
- 2020$36.05B+78.5%
- 2019$20.19B+91.1%
- 2018$10.57B+113.3%
- 2017$4.95B-0.8%
- 2016$4.99B-23.6%
- 2015$6.54B+57.9%
- 2014$4.14B+64.4%
- 2013$2.52B+169.4%
- 2012$934.32M+52.8%
- 2011$611.39M-21.2%
- 2010$776.12M+116.6%
- 2009$358.32M+340.3%
- 2008$81.38M-67.5%
- 2007$250.29M-7.0%
- 2006$269.09M-4.8%
- 2005$282.65M—
Market Cap values are taken from DexCom's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's latest reported market cap is $24.72B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
DexCom (DXCM) most recent annual market cap stands at $29.67B (2026) – grew 10.2% year-over-year.
DexCom market cap has contracted on net over the period, with a -12.4% compound annual growth rate over 2021–2026 (5 years).
DexCom market cap plunged from $57.56B in 2021 to $29.67B in 2026, a 48.5% drawdown.
2021 marks the peak market cap at $57.56B, with the historical low of $81.38M recorded in 2008.
DexCom Market Cap by Year
DexCom Market Cap 2026: $29.67B
In 2026, DexCom reported market cap of $29.67B, grew 10.2% from 2025.
DexCom Market Cap 2025: $26.91B
DexCom market cap in 2025 was $26.91B, declined 16.1% below 2024.
DexCom Market Cap 2024: $32.10B
2024's market cap for DexCom came in at $32.10B, plunged 39.2% below 2023.
DexCom Market Cap 2023: $52.80B
DexCom posted market cap of $52.80B in 2023, grew 9.1% from 2022.
DexCom Market Cap 2022: $48.41B
DexCom market cap in 2022 was $48.41B.
See more financial history for DexCom (DXCM).
Sector peers by Market Cap
Healthcare peers of DexCom (DXCM), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $391.50B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $194.99B | |
| $191.70B |
- $1.07T
- $579.83B
- $391.50B
- $371.00B
- $294.03B
- $277.22B
- $194.99B
- $191.70B
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation